Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AJJ Medtech HoldingsSGX:584 Days Payable is 394.44 as of Mar. 2026, which is 316% above its 10-year median of 94.91. The stock has 4 warning signs investors should review. Among 794 Medical Devices & Instruments companies, AJJ Medtech Holdings ranks better than 92.19% on this metric.
The historical rank and industry rank for AJJ Medtech Holdings's Days Payable or its related term are showing as below:
SGX:584'
s Days Payable Range Over the Past 10 Years
Min: 21.85 Med: 94.91 Max: 486.67
Current: 475.81
During the past 13 years, AJJ Medtech Holdings's highest Days Payable was 486.67. The lowest was 21.85. And the median was 94.91.
SGX:584's Days Payable is ranked better than 92.19% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.85
vs SGX:584: 475.81
AJJ Medtech Holdings's Days Payable
declined
from Mar. 2025 (561.19) to Mar. 2026 (394.44).
It may suggest that AJJ Medtech Holdingsaccelerated paying its suppliers.
AJJ Medtech Holdings Days Payable Related Terms
AJJ Medtech Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for AJJ Medtech Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, AJJ Medtech Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AJJ Medtech Holdings Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AJJ Medtech Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where AJJ Medtech Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
AJJ Medtech Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AJJ Medtech Holdings (SGX:584) has a Days Payable of 394.44 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on AJJ Medtech Holdings and its competitors. This is 316% above median its historical median of 94.91. Over the past decade, AJJ Medtech Holdings' Days Payable has ranged from 21.85 to 486.67. According to the industry distribution chart, AJJ Medtech Holdings ranks #62 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 7.8%.
Is AJJ Medtech Holdings' Days Payable too high?
AJJ Medtech Holdings' current Days Payable of 394.44 is 316% above median its 10-year median of 94.91. Over the past 10 years, this metric has ranged from a low of 21.85 to a high of 486.67. The Medical Devices & Instruments industry median Days Payable is 67.85. AJJ Medtech Holdings' value of 394.44 is 481.3% above this industry median. Based on the distribution chart, AJJ Medtech Holdings ranks #62 out of 794 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does AJJ Medtech Holdings' Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, AJJ Medtech Holdings ranks #62 out of 794 companies for Days Payable. This places AJJ Medtech Holdings in the top 8% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.85. AJJ Medtech Holdings' value of 394.44 is 481.3% above this benchmark. Historically, AJJ Medtech Holdings' own Days Payable has ranged from 21.85 to 486.67 over the past decade. While the company's 10-year median is 94.91 vs. the industry median of 67.85, AJJ Medtech Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.85, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AJJ Medtech Holdings's current Days Payable of 394.44 is 481.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on AJJ Medtech Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AJJ Medtech Holdings's current Days Payable is 394.44, which is 316% above median its own 10-year median of 94.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AJJ Medtech Holdings stock overvalued right now?
Based on GuruFocus' analysis, AJJ Medtech Holdings (SGX:584) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.01, compared to a current price of S$0.01 — trading 50% below its estimated fair value. The current Days Payable is 394.44, which is 316% above median its 10-year median of 94.91 and 481.3% above the Medical Devices & Instruments industry median of 67.85. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For AJJ Medtech Holdings (SGX:584), the current Days Payable is 394.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AJJ Medtech Holdings Ltd is a healthcare technology company building an integrated platform across medical devices, digital systems, and intelligent care infrastructure in Singapore, Southeast Asia, and selected international markets. It integrates artificial intelligence, robotics, and healthcare systems to support healthcare delivery across the patient care continuum. Its portfolio includes diagnostic systems, medical and dental devices, consumables, digital and robotics-enabled healthcare solutions, and turn-key supply-chain solutions. Its segments are corporate and investment holding, healthcare products and services, and healthcare digital products, which generate maximum revenue. It operates mainly in Singapore, and its revenue is derived from the sale of medical healthcare products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:584 has been successfully added to your 
